Top Markets
#1 Black Phoenix Black Phoenix +17,818.82%
#2 Cash Dog in Hood Cash Dog in Hood +6,488.56%
#3 up up +70.00%
#4 AgentFun.AI AgentFun.AI +54.83%
#5 Quai Network Quai Network +41.96%
#6 Arrow Arrow +38.24%
#7 Octra Octra +34.92%
#8 B3 (Base) B3 (Base) +32.40%
#9 Derive Derive +32.29%
#10 Nockchain Nockchain +29.33%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Rangering i aksjer #15063
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Aksjekurs
$4.66
Markedsverdi
$43.92M
Endring (1 dag)
-0.63%
Endring (1 år)
338.04%
Land
FR
Handel Theranexus Société Anonyme (ALTHX)

Kategori

Healthcare
Inntekter for Theranexus Société Anonyme (ALTHX)
Inntekter i Dec 2025 TTM: $-4.69M
Ifølge Theranexus Société Anonyme sine nyeste økonomiske rapporter er selskapets nåværende resultat $-4.69M. I 2023 hadde selskapet et resultat på $-8.43M, en nedgang sammenlignet med resultatet i 2022, som var $-7.71M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Theranexus Société Anonyme fra 2015 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $-4.69M 78.02%
2024 $-2.64M -68.75%
2023 $-8.43M 9.42%
2022 $-7.71M -31.59%
2021 $-11.27M 59.76%
2020 $-7.05M -17.48%
2019 $-8.55M 5.93%
2018 $-8.07M 136.36%
2017 $-3.41M 49.60%
2016 $-2.28M 87.07%
2015 $-1.22M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
$24.72B -526,837.33%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.17B -110,182.16%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.16B -109,994.63%
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -45,654.73%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.66B -35,379.08%
NL